AÉROPORTS-DE-PARIS
After winning the architecture competition in September 2014 to design Beijing's new International Airport, ADP Ingénierie (ADPI), a wholly-owned subsidiary of Aéroports de Paris (Paris:ADP) (OTC Pink:AEOPF) , is expanding its business in Asia, especially in China. This has been achieved through the winning of a series of significant contracts in this region of the world, which enjoys very strong growth in air traffic.
-
In conjunction with Chinese partners, ADPI has won the
international competition for the master plan and the architecture of
the first terminal of the new airport in Chengdu,
the capital of
Sichuan province, in China.
The competition was won in the face of prestigious competitors, including a large number of first-rate international agencies.
-
In partnership with the local branch of global engineering
specialists, Meinhardt, ADPI has won two calls for tender issued by
Hong Kong International Airport
(HKIA) for the design
of:
- an extension to the main terminal (Terminal 1) allowing an increase in capacity of 10 million passengers. This involves primarily expanding the terminal’s landside area in order to enhance the check-in and baggage-handling facilities, as well as passenger flows;
- an extension of the aprons to provide parking space for 24 additional widebody aircraft.
A major hub in Asia, Hong Kong International Airport welcomed 64 million passengers in 2014 and holds first place worldwide for air cargo. The airport is internationally renowned for its quality of service and its environmental performance.
For both of these projects, the ADPI teams are providing their clients with their know-how regarding planning and studies of airport systems and specific airport equipment, all while faced with the challenge of carrying out the project without disrupting daily traffic (construction while in operation).
-
ADPI has been selected, by the Chinese authorities and one of the
main local design institutes, to audit the future development projects
at Shanghai Pudong International Airport
.
Against this background, ADPI provided a high value-added service allowing them to validate the developments planned by the authorities, to identify and develop possible functional improvements in order to optimise airport operations and generate productivity gains.
This new contract illustrates the quality of the relationship between ADPI and Shanghai Pudong Airport. The airport had already previously chosen Aéroports de Paris at the end of the 1990s, for the preparation of the Master Plan and to carry out studies on the first terminal.
-
Lastly, ADPI has recently been selected to conduct upstream studies
on two provincial airports in South Korea:
- the first study aims to verify the feasibility of the expansion of Jeju International Airport (the country's third-largest airport with 23 million passengers in 2014) in order to determine the critical parameters, particularly in terms of the capacity of existing aeronautical facilities;
- the second study, currently undertaken in consortium with the Korean Transport Institute (KOTI), examines the feasibility study for a new airport in Youngnam, a region in the south-east of the country.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005953/en/
Contact:
Aéroports de Paris
Press contact
:
Elise Hermant,
+33 1 43 35 70 70
Opinion Department Manager
or
Investor
Relations
:
Aurélie Cohen, +33 1 43 35 70 58
Investor
Relations Manager
invest@adp.fr
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum